Luye Pharma Group Ltd. (02186.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 1.72

From 52W high−53.58%

Volume46.50M

Market capHKD 7.08B

P/E (TTM)8.7x

P/S (TTM)1.0x

Div yield—

Key dataSep 18, 2026

Open

HKD 1.72

From 52W high

−53.58%

Volume

46.50M

Market cap

HKD 7.08B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.3x

P/E (TTM)

8.7x

RSI (14)

34.4

MomentumView details →

1D Return

+2.94%

YTD Return

−36.13%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

8.7x

EV/EBITDA

3.3x

EV/Sales

1.2x

P/S (TTM)

1.0x

P/B (TTM)

0.4x

ProfitabilityView details →

Gross Margin

63.75%

Net Margin

11.35%

EBITDA Margin

36.18%

ROE (TTM)

4.44%

ROA (TTM)

1.98%

Asset Turnover

0.18x

GrowthView details →

Revenue YoY

−1.30%

EPS YoY

+63.51%

FCF YoY

−62.92%

Revenue CAGR 3Y

+1.79%

EPS CAGR 3Y

−2.00%

EBITDA YoY

+27.48%

MomentumView details →

1D Return

+2.94%

YTD Return

−36.13%

1Y Return

−50.28%

RSI (14)

34.4

vs 50D SMA

−13.52%

vs 200D SMA

−27.70%

Capital & dividendView details →

Debt/Equity

0.81x

Current Ratio

1.45x

Quick Ratio

1.37x

Div Yield

—

Div Rate

—

Div Growth 1Y

−54.55%

EarningsView details →

EPS (Actual)

HKD 0.03

EPS Surprise

−48.80%

Beats (12Q)

0/12

Next Q EPS Est

—

Avg Surprise (4Q)

−48.80%

Rev Surprise

−5.13%

Financials snapshotView financials →

Revenue (TTM)

12.26B

Net Income (TTM)

1.09B

Op. CF (TTM)

2.69B

Next earningsMar 31, 2027 →

Latest newsMore news →

Shandong Commercial Group transferred 5% of Furuida's shares to Shandong State-owned Assets Investment Holding Co., Ltd., completing registration on August 31, 2026.19d ago

Luye Pharma Group announced its interim results for the six months ended June 2026, with net profit of RMB 390 million, up 24.8% year-on-year, and revenue of RMB 3.002 billion, down 5.6%.21d ago

Similar companies

广誉远600771.SH 奥瑞德600666.SH 神奇制药600613.SH Grifols, S.A.GRFS Tong Ren Tang Technologies Co. Ltd.01666.HK Impact Therap-b07630.HK Find similar companies →

Latest newsMore news →

Shandong Commercial Group transferred 5% of Furuida's shares to Shandong State-owned Assets Investment Holding Co., Ltd., completing registration on August 31, 2026.19d ago Luye Pharma Group announced its interim results for the six months ended June 2026, with net profit of RMB 390 million, up 24.8% year-on-year, and revenue of RMB 3.002 billion, down 5.6%.21d ago